« Previous
Next »
Titles
- The impact of COVID-19 on the rural health care landscape: challenges and opportunities1
- The opioid crisis and recent federal policy responses1
- The prices that commercial health insurers and Medicare pay for hospitals’ and physicians’ services1
- The risk of misuse and diversion of buprenorphine for opioid use disorder appears to be low in Medicare Part D1
- The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 20221
- The role of health and human service providers in preventing fetal alcohol spectrum disorder1
- The role of telehealth in achieving a high performing rural health system: priorities in a post-pandemic system1
- Tobacco products: principles for designing and conducting tobacco product perception and intention studies1
- Toolkit: analyzing telehealth claims to assess program integrity risks1
- Tracking the funds. Specific fiscal year 2023 provisions for the Office of National Drug Control Policy1
- Tracking the funds: specific fiscal year 2022 provisions for Department of Health and Human Services : report to congressional committees1
- Transition options, opportunities for integration, and funding considerations following coordinated specialty care1
- Transition plan for medical devices issued emergency use authorizations (EUAs) related to coronavirus disease 2019 (COVID-19): guidance for industry, other stakeholders, and Food and Drug Administration staff1
- Transition plan for medical devices that fall within enforcement policies issued during the coronavirus disease 2019 (COVID-19) public health emergency: guidance for industry, other stakeholders, and Food and Drug Administration staff1
- Trends in COVID-19 vaccination intentions1
- Trends in ownership structures of U.S. nursing homes and the relationship with facility traits and quality of care (2013-2022)1
- Trends in prescription drug spending: 2016-20211
- Tribal epidemiology centers: HHS actions needed to enhance data access : report to congressional addressees1